Qube Research & Technologies (QRT)
VOR icon

Qube Research & Technologies (QRT)’s Vor Biopharma VOR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,410
Closed -$34.6K – 4017
2025
Q1 		$34.6K Buy
+2,410
New +$57.9K ﹤0.01% 3170
2024
Q4 		– Sell
-1,541
Closed -$21.6K – 3848
2024
Q3 		$21.6K Sell
1,541
-3,227
-68% -$58.8K ﹤0.01% 2967
2024
Q2 		$95.4K Buy
+4,768
New +$154K ﹤0.01% 2613
2023
Q2 		– Sell
-2,687
Closed -$289K – 3074
2023
Q1 		$289K Buy
2,687
+1,695
+171% +$188K ﹤0.01% 1772
2022
Q4 		$132K Buy
992
+250
+34% +$24.7K ﹤0.01% 1933
2022
Q3 		$59K Sell
742
-73
-9% -$7.18K ﹤0.01% 2103
2022
Q2 		$81K Sell
815
-1,057
-56% -$108K ﹤0.01% 2014
2022
Q1 		$226K Sell
1,872
-319
-15% -$54.3K ﹤0.01% 1906
2021
Q4 		$509K Buy
2,191
+1,491
+213% +$430K ﹤0.01% 1559
2021
Q3 		$220K Buy
+700
New +$208K ﹤0.01% 1617
2021
Q2 		– Sell
-453
Closed -$391K – 2844
2021
Q1 		$391K Buy
+453
New +$383K 0.01% 1319

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VOR Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of Vor Biopharma (VOR) in Q2 2025, closing a stake of 2,410 shares — an estimated $34.6K sold.

Qube Research & Technologies (QRT) first reported a position in VOR in Q1 2021 and held it in 11 quarters. The position peaked at $509K in Q4 2021. 35 funds tracked by Wall St. Rank hold VOR as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining Vor Biopharma position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,410 Vor Biopharma shares in Q2 2025, an estimated $34.6K.
  • Qube Research & Technologies (QRT) first reported a position in Vor Biopharma in Q1 2021 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Vor Biopharma position peaked at $509K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.